Cited by

• The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

  Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma). Kumar A, et al. J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S3-S26. doi: 10.1016/j.jceh.2014.04.003. Epub 2014 May 22. J Clin Exp Hepatol. 2014. PMID: 25755608 Free PMC article. Review.
• Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.

  Wu P, Dugoua JJ, Eyawo O, Mills EJ. Wu P, et al. J Exp Clin Cancer Res. 2009 Aug 12;28(1):112. doi: 10.1186/1756-9966-28-112. J Exp Clin Cancer Res. 2009. PMID: 19674474 Free PMC article.
• Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma.

  Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R. Sherman M, et al. Curr Oncol. 2011 Oct;18(5):228-40. doi: 10.3747/co.v18i5.952. Curr Oncol. 2011. PMID: 21980250 Free PMC article.
• Quality assessment of clinical practice guidelines on the treatment of hepatocellular carcinoma or metastatic liver cancer.

  Wang Y, Luo Q, Li Y, Wang H, Deng S, Wei S, Li X. Wang Y, et al. PLoS One. 2014 Aug 8;9(8):e103939. doi: 10.1371/journal.pone.0103939. eCollection 2014. PLoS One. 2014. PMID: 25105961 Free PMC article.
• Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective.

  Hafeez Bhatti AB, Dar FS, Waheed A, Shafique K, Sultan F, Shah NH. Hafeez Bhatti AB, et al. Gastroenterol Res Pract. 2016;2016:5942306. doi: 10.1155/2016/5942306. Epub 2016 Feb 3. Gastroenterol Res Pract. 2016. PMID: 26955390 Free PMC article. Review.